CEO Succession Planning in the United States

COO Appointment with Defined CEO Succession Path and Strategic Relocation to Texas in a European Medical Technology Company

Global Company Profile

Company Type

European medical technology manufacturer

Ownership

Private, family-owned company (third generation leadership)

Global Revenue

Approx. €110M at time of U.S. search mandate

Employees

600+ internationally

Product Areas

Surgical implant systems; contrast media injection systems; surgical instruments

Global Markets

Distribution and commercial presence in more than 50 countries

U.S. Organization

Market Entry

Mid-2000s

Strategic Purpose

Establish and expand the company’s presence in the United States medical technology market

Relocation

U.S. operations relocated from the Midwest to Dallas, Texas

Staff | Sales

37 | Approximately $25M–$35M

Go to Market

Independent distributors, direct sales, and strategic channel partners | Surgeons and hospital systems

Leadership Context

CEO retirement after 15 years in role

A Dual Challenge: CEO Succession and Headquarters Relocation

The U.S. subsidiary of a European medical device manufacturer faced two simultaneous leadership challenges: a structured CEO succession and a cross-country relocation of its entire U.S. operation.

The long-serving CEO had informed ownership that he intended to retire within twelve months. At the same time, the European parent decided to relocate the U.S. organization from the Midwest to Dallas, Texas — to improve market access, scalability, and long-term positioning in North America.

The relocation was already underway. A significant portion of existing leadership and key personnel, however, was unwilling to make the move. This created compounding risks across operational continuity, regulatory compliance, and leadership capacity at the new location.

Ownership was now managing four challenges simultaneously:

  • Executing a defined CEO succession in the U.S. subsidiary
  • Stabilizing the organization through an active relocation
  • Maintaining regulatory and operational continuity in a medical device environment
  • Rebuilding core leadership capacity at the new Texas site

Preserving operational stability — and the governance relationship between the European parent and the U.S. subsidiary — was the board's top priority.

Against this backdrop, TH Bender was retained to identify a Texas-based COO with a clearly defined path to the CEO role — succession readiness built into the position from the outset.

Vertrauliches CEO-Nachfolge-Framework und Relocation-Strategie-Dokument auf dunklem Schreibtisch mit Stadtlichtern im Hintergrund – symbolisiert die doppelte Herausforderung aus CEO-Nachfolge und Standortverlagerung nach Texas in einem europäischen Medizintechnikunternehmen
Regulatorische Risikobewertungs-Checkliste und MDR-Compliance-Dokument mit roten Annotationen auf klinischer Oberfläche vor der Skyline von Dallas – symbolisiert die regulatorischen Risikodimensionen bei einer CEO-Nachfolge in einem Medizintechnikunternehmen in Texas

Five Risk Dimensions. All at Once.

Few mandates combine this many structural risks simultaneously:

  • A publicly announced CEO retirement with a fixed succession deadline
  • An active cross-country relocation of the entire U.S. organization — Midwest to Dallas
  • Significant loss of existing leadership and key personnel unwilling to relocate
  • Regulatory accountability in a compliance-intensive medical device environment
  • Crossborder governance alignment between the European parent and the U.S. subsidiary in flux

The role required an executive with the operational depth to stabilize the organization immediately, the strategic maturity to earn trust on both sides of the Atlantic, and the leadership profile to step into the CEO seat within twelve months.

Relocation-Ready. CEO-Ready. Both Required.

The search was run as a retained, exclusive engagement with national reach — prioritizing candidates already in Texas or prepared to relocate.

Two objectives had to be met with a single hire: stabilize the organization through an active cross-country move, and place someone capable of running the U.S. business within twelve months.

The search was built around five criteria:

  • National market mapping across the medical device sector
  • Identification of candidates based in Texas or with a genuine commitment to relocating with hands-on operational experience and CEO potential
  • Structured evaluation of CEO succession readiness — not just fit for the COO role
  • Multi-round interviews and senior reference checks to validate leadership depth and governance capability
  • Continuous alignment with European parent leadership on succession design and leadership requirements

One search. Two problems solved.

Kandidatenbewertungsraster mit Relocation-Bereitschaft und CEO-Nachfolgepotenzial auf dunklem Schreibtisch vor der Skyline von Dallas und einer Texas-Karte

COO on Day One. CEO in Twelve Months.

A Texas-based COO was placed and moved quickly to stabilize the organization through the active relocation. In the first twelve months, the new COO :

.

  • Maintained operational continuity throughout the cross-country move
  • Built core leadership capacity at the new Dallas location
  • Ensured egulatory continuity in a compliance-sensitive medical device environment
  • Established credibility with both the U.S. team and the European parent

Twelve months after joining — on the timeline defined at the outset — the COO assumed the CEO role of the U.S. subsidiary.

The succession executed without operational disruption. Governance alignment between the European parent and the U.S. organization held throughout the entire transition.

Perspective from the Group CEO

Translated from German: "“We are a well-established manufacturer of implants and contrast agents. As part of the succession of our long-standing CEO, who retired, we used the opportunity to relocate the company to Texas. This required building a largely new team.

THBender presented several highly qualified candidates. We were particularly impressed by the strategic ideas the candidates brought forward for the development of our U.S. business.

The TH Bender team played a leading role in building trust — which ultimately enabled an open exchange of ideas and concepts.”

- Group CEO / Shareholder

Frequently Asked Questions: CEO Succession in the U.S.

CEO succession in medical devices demands more than general leadership experience. Candidates must combine P&L accountability with regulatory fluency and deep market relationships in the U.S. healthcare system. A specialized executive search ensures that assessment goes beyond operational credentials — to include the strategic maturity and cross-border management capability that international ownership structures require.

A search partner with genuine sector depth brings active relationships across hospitals, GPOs, IDNs, and specialized distribution channels — not just a database. For European companies with U.S. subsidiaries, this translates directly into access to candidates who combine medical device industry knowledge, regulatory experience, willingness to relocate, and the leadership profile required for CEO succession.

A structured CEO succession in the U.S. bridges European governance expectations with the realities of the American market. A retained search process creates an objective decision-making foundation — giving owners and boards the confidence to execute leadership transitions that are stable in the short term and sustainable over time.

The right candidate combines hands-on operational management, P&L accountability, and substantive medical device market knowledge. Equally important: the strategic range to think beyond the COO role, the ability to work effectively across the Atlantic between a European parent and a U.S. organization, and a genuine readiness to assume CEO responsibility within a defined transition window.

A fixed CEO succession deadline running in parallel with an active cross-country relocation — each challenging on its own. Together, they required stabilizing an organization mid-move, rebuilding core leadership capacity at a new location, and maintaining governance alignment between the European parent and the U.S. subsidiary. All at once, with no margin for delay.

Stehen Sie vor einer CEO-Nachfolge oder strategischen Führungsentscheidung in den USA?

Ein vertraulicher Austausch kann helfen, Nachfolgestruktur, Standortstrategie und Executive-Search-Vorgehen für Ihre US-Tochtergesellschaft klar zu strukturieren.

Or email us at info@thbender.com